Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zealand Pharma A/S ADR (ZEAL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 469,860
  • Shares Outstanding, K 30,750
  • Annual Sales, $ 21,230 K
  • Annual Income, $ -41,360 K
  • 36-Month Beta N/A
  • Price/Sales 22.14
  • Price/Cash Flow N/A
  • Price/Book 6.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.01 +28.64%
on 07/03/18
15.75 -1.90%
on 07/17/18
+0.68 (+4.60%)
since 06/20/18
3-Month
12.01 +28.64%
on 07/03/18
16.70 -7.49%
on 05/23/18
+0.55 (+3.69%)
since 04/20/18
52-Week
12.01 +28.64%
on 07/03/18
20.37 -24.15%
on 09/08/17
-2.37 (-13.30%)
since 08/09/17

Most Recent Stories

More News
Blog Exposure - Zealand's End-of-Phase-2 Meeting with FDA Confirmed the Path Forward for Phase-3 Program of Glepaglutide for Short Bowel Syndrome

Stock Monitor: Cytokinetics Post Earnings Reporting

ZEAL : 15.45 (+1.11%)
Zealand announces grant of new warrants under employee warrant programme

Zealand Pharma A/S (CPH:ZEAL), a biotechnology company focused on the discovery, design and development of peptide-based medicines, announced on Friday the grant of warrants to the company's president...

ZEAL : 15.45 (+1.11%)
Zealand announces grant of new warrants under employee warrant programme

Zealand Pharma A/S (CPH:ZEAL), a biotechnology company focused on the discovery, design and development of peptide-based medicines, announced on Friday the grant of warrants to the company's president...

ZEAL : 15.45 (+1.11%)
Capsicum Re Names Head of New Mortgage Indemnity Reinsurance Division

Specialty reinsurance broker Capsicum Re said it appointed Steven Rance to lead a new business division that will focus on mortgage indemnity reinsurance.

AKTX : 2.08 (+0.97%)
ZEAL : 15.45 (+1.11%)
Nasdaq Welcomes Zealand Pharma (Nasdaq:ZEAL) to The Nasdaq Stock Market

Zealand Pharma (Nasdaq:ZEAL), a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines, visited the Nasdaq MarketSite in Times Square today in celebration...

NDAQ : 95.00 (unch)
ZEAL : 15.45 (+1.11%)
Zealand Pharma (Nasdaq: ZEAL) to Ring The Nasdaq Stock Market Opening Bell

What:

NDAQ : 95.00 (unch)
ZEAL : 15.45 (+1.11%)
Zealand Pharma reports royalty revenues of DKK9.1m in Q2 2017

Zealand Pharma A/S (CPH:ZEAL), a biotechnology company focused on the discovery, design and development of peptide-based medicines, on Monday reported royalty revenues for Q2 2017 from Sanofi's sales of...

ZEAL : 15.45 (+1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ZEAL with:

Business Summary

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.

See More

Key Turning Points

2nd Resistance Point 15.64
1st Resistance Point 15.54
Last Price 15.45
1st Support Level 15.26
2nd Support Level 15.08

See More

52-Week High 20.37
Fibonacci 61.8% 17.18
Fibonacci 50% 16.19
Last Price 15.45
Fibonacci 38.2% 15.20
52-Week Low 12.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar